Smoking Cessation
📧 Sign up to get email alerts when something new happens for Smoking Cessation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors. [Phase 4]
Phase 4 clinical trial results for Project HOPES evaluating healthy options for pain management and smoking cessation in cancer survivors; r…
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Efficacy of a Smoke-Free Homes Intervention [NA]
Clinical trial results on a smoke-free homes intervention showing outcomes for smoking cessation.
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Results: Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation [Phase 4]
Phase 4 trial comparing self-directed titrated transdermal nicotine patch to standard treatment for smoking cessation; results completed wit…
-
CLINICAL_TRIALS trial_result · 2026-08-10Clinical Trial Results: Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease [Phase 4]
Phase 4 trial evaluating efficacy and cost-effectiveness of cost-free pharmacotherapy for smoking cessation in high-risk smokers with cerebr…
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Results: Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers [NA]
Completed clinical trial evaluating a tobacco treatment program for underserved smokers in partnership with a food bank.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: WeChat Quit Coach Pilot Study [NA]
Pilot study results from a WeChat Quit Coach program for smoking cessation have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness [Phase 4]
Phase 4 clinical trial evaluating the PARQuit smoking cessation intervention for adults with serious mental illness completed.
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness [NA]
Pilot clinical trial results evaluating a digital intervention to improve smoking cessation in people with serious mental illness.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study [Phase 4]
Phase 4 clinical trial results for the BREATHE 2 Clinic Stop-Smoking Treatment Outreach study have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Testing the Integrated mHealth App Intervention "SiS-H" [NA]
Completed clinical trial results for the integrated mHealth app intervention SiS-H targeting smoking cessation were posted.
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: Combining Varenicline and Guanfacine for Smoking Cessation [Phase 2]
Phase 2 clinical trial investigating the combination of varenicline and guanfacine for smoking cessation has completed with results posted.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT) [NA]
A research trial evaluating metabolism-informed care to aid Alaska Native people in quitting smoking (QUIT); recruitment is ongoing.
-
FDA approval · 2026-02-25FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, granting approval for the supplemental use of this…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Health Communications for Adults Smoking Nondaily [NA]
Clinical trial update for a health communications intervention targeting nondaily adult smokers; the study is not yet recruiting.
-
FDA approval · 2026-02-05FDA Approved: NICOTINE — Supplemental Application (McKesson Corporation dba SKY Packaging)
FDA approved a supplemental application for NICOTINE (nicotine polacrilex) submitted by McKesson Corporation dba SKY Packaging.
-
FDA approval · 2025-12-18FDA Approved: VARENICLINE TARTRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lupin Pharmaceuticals’ varenicline tartrate product, indicating approval of a change to the appr…
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride (generic) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals …
-
FDA approval · 2025-10-29FDA Approved: VARENICLINE TARTRATE — Original Application (Micro Labs Limited)
FDA approved the original ANDA for Varenicline tartrate from Micro Labs Limited. This approval confirms Micro Labs Limited's generic product…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Evaluation of Cessation Preferences of Menthol Smoker [NA]
A completed clinical trial from the University of Minnesota evaluating cessation preferences among menthol smokers.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Study of a Smartphone-Based Switch Program [NA]
Completed clinical trial evaluating a smartphone-based switch program for smoking cessation.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Suvorexant to Reduce Symptoms of Nicotine Use [Phase 2]
Phase 2 trial evaluating suvorexant for reducing nicotine withdrawal symptoms in adults seeking smoking cessation has completed, and results…
-
FDA approval · 2025-06-24FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for CHANTIX (varenicline tartrate) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2025-05-02FDA Approved: VARENICLINE — Original Application (Aurobindo Pharma Limited)
The FDA approved a generic version of varenicline from Aurobindo Pharma Limited via an Original Application (ANDA) for smoking cessation.
-
FDA approval · 2025-03-14FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for bupropion hydrochloride from Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Establishing the Effectiveness of Publicly Available Smoking Cessation Resource [NA]
Completed University of Virginia clinical trial evaluating the effectiveness of a publicly available smoking cessation resource; results wer…